The europe pregnancy and fertility testing market size was valued at USD 271.7 billion in 2021 and is poised to grow at a significant CAGR of 4.7% during the forecast period 2022-28. Fertility testing refers to medical and physical assessments that analyses the ability to conceive. Fertility refers to a disease of the reproductive system that results in the inability to get pregnant, or inability to naturally conceive, and have children, while fertility refers to a disease of the reproductive system that results in the inability to get pregnant, or inability to naturally conceive, and have children. The test is essentially an ovulation evaluation; however, the tests vary by gender. For women, the tests include ovulation testing, ovarian function testing, luteal phase testing, and a hormone test; for men, the tests include hormone testing, semen analysis, testicular biopsy, genetic testing, imaging, and other specialty testing.
View detailed report description at https://precisionbusinessinsights.com/market-reports/europe-pregnancy-fertility-testing-market/
In the forecast timeframe of 2020 to 2027, the Europe Pregnancy and Fertility Testing Market is anticipated to grow at a CAGR of 5.30 percent. The dissemination of knowledge among physicians and convicts about the benefits and availability of equipment would aid in the market's growth. Grown demand for infertility testing to discover the cause of the illness and diagnose it has increased due to shifting lifestyles and growing infertility disorders in both male and females, while advancements in technology will fuel market development. The industry is being driven by rising first-time pregnancy rates, falling fertility rates, and advances in technology that can accurately assess fertility. Furthermore, the availability of decentralized diagnostic tests as an alternative to time-consuming laboratory testing, as well as increased awareness of these tests, will drive market development in the future years. Nonetheless, market constraints include the low accuracy of ovulation prediction kits and the limited precision of urine-based ovulation trackers in PCOS/PCOD patients. Furthermore, the high price of fertility monitors would stifle market expansion, while unwillingness to conduct fertility testing in some developing countries will provide a barrier. In the next years, the market will benefit from innovation and the creation of new and efficient methods.
The Europe Pregnancy and Fertility Testing Market is fragmented in terms of sample, product, mode of purchase, and end-use. On the basis of type of product, the Europe fertility testing market is categorized into fertility monitors, ovulation predictor kits, male fertility testing products, and others. On the basis of sample, the Europe fertility testing market is divided into urine, saliva, blood and others. In terms of mode of purchase, the Europe fertility testing market is classified into prescription and OTC. In terms of end use, the market is segregated into fertility clinics, hospitals, home care, and others.
Request sample report https://precisionbusinessinsights.com/request-sample?product_id=17854
Germany is anticipated to have the highest market share throughout the projection period, mainly due to government expenditure on healthcare infrastructure and technological advancements. Furthermore, growing occurrences of infertility have boosted market demand, which would drive market expansion during the forecast period. According to the European Commission, the birth rate is declining at a substantial pace as a result of infertility problems, which has raised market demand.
The europe pregnancy and fertility testing market segmentation:
- By Product Type (Pregnancy Test Kits (Strips/Dip Sticks, Midstream Kits, Card or Cassette Kits, and Digital Devices) Fertility/Ovulation Test Kits (Line Indicator Devices and Digital Devices)),
- By Test Type (HCG Urine Test, HCG Blood Test, FSH Urine Test, and LH Urine Test),
- By End User (Hospitals, Clinics, Homecare, and Diagnostics Centers)
There are some key players working in the europe pregnancy and fertility testing market, which include Abbott Laboratories, Alere Inc., bioMérieux SA, Church & Dwight Co., Inc., DCC Plc., Geratherm Medical AG, Germaine Laboratories, Kent Pharmaceuticals, Prestige Brands Holdings, Procter & Gamble Co., Quidel Corporation, Rite-Aid, Swiss Precision Diagnostics GmbH
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights| Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174